The future of blood-based biomarkers for Alzheimer’s disease

Treatment of Alzheimer’s disease (AD) is significantly hampered by the lack of easily accessible biomarkers that can detect disease presence and predict disease risk reliably. Fluid biomarkers of AD currently provide indications of disease stage; however, they are not robust predictors of disease pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Henriksen, Kim, O’Bryant, Sid E., Hampel, Harald, Trojanowski, John Q., Montine, Thomas J., Jeromin, Andreas, Blennow, Kaj, Lönneborg, Anders, Wyss-Coray, Tony, Soares, Holly, Bazenet, Chantal, Sjögren, Magnus, Hu, William, Lovestone, Simon, Karsdal, Morten A., Weiner, Michael W.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4128378/
https://ncbi.nlm.nih.gov/pubmed/23850333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2013.01.013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars